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Induction of ornithine decarboxylase (ODC), a key enzyme in poly-
amine biosynthesis, in ODC transgenic skin stimulates epidermal
proliferation but not hyperplasia, activates underlying stromal cells
and promotes skin tumorigenesis following a single subthreshold
dose of a carcinogen. Because chronic wounds are a well-recognized
risk factor for skin cancer, we investigated the response to a tissue
remodeling event in normal skin that is abraded to remove only the
epidermal layer in K6/ODC transgenic (follicular ODC expression)
and in inducible ODCER transgenic mice (suprabasal ODC expres-
sion). When regenerative epidermal hyperplasia was resolved in
normal littermates following abrasion, ODC transgenic mice ex-
hibited progressive epidermal hyperplasia with formation of be-
nign tumor growths and maintained an increased epidermal
proliferation index and activation of translation-associated pro-
teins at abrasion sites. The epidermal hyperplasia and tumor-like
growth was accompanied by activation of underlying stromal cells
and prolonged infiltration of inflammatory cells. Treatment with the
anti-inflammatory agent dexamethasone did not reduce the high
proliferative index in the regenerated epidermis but dramatically
reduced the epidermal hyperplasia and prevented the wound-
induced tumor growths in abraded ODCER skin. Treatment with
a-difluoromethylornithine, a specific inhibitor of ODC activity, nor-
malized the wound response in transgenic mice and decreased
wound-induced inflammation if administered from the time of abra-
sion but not if initiated 4 days following abrasion. These results
suggest a role for polyamines in prolonging wound-associated in-
flammation in addition to stimulating proliferation both of which
are sufficient to sustain epidermal hyperplasia and benign tumor
growth even in the absence of genetic damage.
Introduction
Polyamines have long been known to be associated with cell prolif-
eration in both normal and neoplastic tissues (1). Tightly regulated
metabolism of polyamines is critical for cell survival and normal skin
homeostasis, and these controls are dysregulated in skin tumorigene-
sis. A key enzyme in polyamine biosynthesis, ornithine decarboxylase
(ODC), is upregulated in both human and animal skin tumors com-
pared with normal skin (2–4). ODC is responsible for the biosynthesis
of the diamine putrescine that is subsequently converted to the poly-
amines spermidine and spermine. ODC expression is upregulated in
tumor epithelial cells by a variety of oncogenes such as c-myc (5, 6),
v-src (7), v-raf (8) or an activated Ras or RhoA (8), all of which also
play essential roles in normal tissue remodeling events such as wound
healing. Use of transgenic mouse models has demonstrated that poly-
amines play an essential role in the early promotional phase of skin
tumorigenesis since elevated epidermal ODC activity is sufficient to
promote skin tumorigenesis following a single subthreshold dose of
a carcinogen (9–11). The formation of skin tumors in these transgenic
mice is dependent upon polyamine biosynthesis, especially putres-
cine, since treatment with inhibitors of ODC activity blocks the for-
mation of skin tumors and causes the rapid regression of existing
tumors (10–13). Although the mechanisms by which polyamines pro-
mote skin tumorigenesis are not well understood, de novo induction of
epidermal ODC activity in ODCER transgenic mice has been shown
to stimulate epidermal proliferation, alter keratinocyte differentiation
status, increase neovascularization but is not sufficient in itself to lead
to epidermal hyperplasia or skin tumor formation (11,14). This poly-
amine-activation of keratinocytes and underlying stromal cells is most
probably an early event in the tumor process that creates a more
permissive microenvironment for tumor development.
Wounding is known to promote the development of tumors (15), and
chronic wounds and acute trauma are well-recognized risk factors for
skin cancer (16–18). Cutaneous injury initiates an intricately regulated
sequence of processes that involve cellular and biochemical events or-
chestrated to repair the wound (19). Wound healing processes involve
cell migration, infiltration of inflammatory cells, proliferation, neoangio-
genesis and extracellular matrix (ECM) degradation and resynthesis.
Although polyamines are essential for cell proliferation and ODC and
polyamine levels increase within 12 h after wounding (20–22), the role of
polyamines during wound repair remains unclear. We describe skin abra-
sion studies using K6/ODC and ODCER transgenic mice to investigate
the wound healing response in a skin microenvironment that is activated
as the result of elevated epidermal polyamine biosynthesis.
Materials and methods
Animals
Mice used in wound healing experiments included K6/ODC transgenic mice,
ODCER transgenic mice and their normal littermates, all backcrossed into
either the FVB or C57BL/6 background for at least 10 generations. A keratin
6 promoter constitutively directs ODC transgene expression to the outer root
sheath cells of hair follicles in K6/ODC transgenic mice (9), and an involucrin
promoter directs the expression of the inducible ODC complementary DNA,
fused in frame to a 4-hydroxytamoxifen (4OHT)-responsive mutant estrogen
receptor ligand-binding domain, to the suprabasal epidermis in ODCER trans-
genic mice (11). K6/ODC transgenic mice exhibit loss of hair accompanied by
the development of dermal cysts from the degenerating hair follicles (9, 23).
Without treatment with the inducing agent, 4OHT, ODCER transgenic mice
demonstrate a low basal ODC activity similar to wild-type mice and have
a normal skin phenotype with no hair loss (11). ODC activity was induced
in ODCER transgenic mice beginning 1 week prior to abrasion by topical
application of 4OHT dissolved in ethanol (1.0 mg/0.1 ml) applied each day
to a shaved area of the dorsal skin just behind the neck and distant to the wound
area (closer to the tail). To inhibit ODC enzyme activity, mice were given 1%
(wt/vol) a-difluoromethylornithine (DFMO) in their drinking water.
Skin abrasion
Regenerative epidermal growth was induced by abrasion of the dorsal skin of 7-
week-old K6/ODC or ODCER transgenic mice and their normal littermates.
Briefly, mice were anesthetized with an intraperitoneal injection of Avertin and
then the dorsal back fur of the non-transgenic haired mice shaved with electric
clippers and depilated with Nair for 2 min. Following careful removal of the Nair,
a 2 cm2 area of the dry dorsum was gently abraded with a felt wheel on a motor
tool leaving the abraded area shiny and pink and bloodless. Some mice were
subcutaneously injected with dexamethasone [100 lg in 100 ll phosphate-buff-
ered saline; Sigma/Aldrich, St. Louis, MO] near the wound site daily starting the
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day after wounding until killing. Two hours before killing, some mice were
injected intraperitoneal with bromodeoxyuridine (BrdU) (Sigma, St Louis, MO)
at a dose of 100 lg/g body wt. Mice were killed 1, 2, 3, 5, 7, 14, 21, 28 and 56 days
following the abrasion, and the dorsal skin removed for analyses.
Autoradiography
Proliferating cells that incorporate [3H]thymidine were detected using autora-
diography as described previously (24). To evaluate the epidermal transit dis-
tance or the distance that a basal cell pulse labeled with [3H]thymidine travels
toward the uppermost layer of the epidermis in a given time, mice were in-
jected intraperitoneally with [methyl-3H] thymidine (specific activity, 45–61
Ci/mmol; Amersham/Searie Corp., Arlington Heights, IL) at a concentration of
30 lCi per mouse on the third day following abrasion and killed 9 h later.
Slides containing 10–12 serial 7 lm sections were deparaffinized, rinsed in
absolute ethanol and dipped in 40C NTB-2 nuclear track emulsion (Eastman
Kodak Co., Rochester, NY) diluted 1:1 with distilled water. The coated slides
were dried in darkness and exposed for 14 days at 4C in light-tight boxes
containing silica gel desiccant. The autoradiographs were developed in Kodak
D-19 for 3 min at 18C, fixed in Kodak fixer, washed in cold running tap water
for 1 h and then lightly stained in hematoxylin and eosin. Nuclei with a min-
imum of three to five silver grains were scored as labeled.
Immunohistochemistry
Mouse skin tissues were fixed in 4% p-formaldehyde in phosphate-buffered
saline overnight and embedded in paraffin. Skin sections were deparaffinized,
hydrated and then heated in 0.01 M sodium citrate buffer (pH 6.0) in a steamer
for 8 min. Sections were incubated with primary antibodies followed by bio-
tinylated secondary antibody and then an avidin horseradish peroxidase com-
plex (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA).
Primary antibodies used were monoclonal antibody against alpha-smooth mus-
cle actin (Biomedia, Foster City, CA); rat anti-mouse neutrophil antibody
recognizing the 7/4 antigen (Clone 7/4; Cedarlane, Burlington, NC); rat mono-
clonal anti-mouse F4-80 antigen (AbD Serotec, Raleigh, NC); rabbit polyclonal
antibody against fibroblast-specific protein-1 or S100A4 (LabVision Corp,
Fremont, CA); rabbit polyclonal antibody against tenascin-C (Chemicon,
Ternecula, CA); rabbit polyclonal anti-spermine oxidase (kind gift from R.
Casero, Johns Hopkins University, Baltimore, MD); rabbit polyclonal antibody
specific for hypusine-containing eukaryotic initiation factor 5A (eIF5A) (kind
gift from M. Park, NIH, Bethesda, MD) and rabbit polyclonal antibodies
against phosphorylated Akt (Ser473) or phosphorylated S6 ribosomal protein
(Ser235/236) both from Cell Signaling Technology (Beverly, MA). Immuno-
reactive cells were localized by incubating the sections with a chromagen
solution containing diaminobenzidine and peroxide and then counterstaining
with hematoxylin. BrdU incorporation in cells undergoing DNA synthesis was
detected in skin sections using a rat monoclonal anti-BrdU antibody (Zymed
Laboratories, San Francisco, CA). Pictures were acquired using a Zeiss Axio-
phot microscope (Carl Zeiss, Oberkochen, Germany), with a digital color cam-
era and corresponding software (Axiocam; Zeiss). All images were processed
for printing using Adobe Photoshop software.
Measure of myeloperoxidase enzyme
Levels of myeloperoxidase (MPO) enzyme were used as an indirect measure of
neutrophil content in abraded tissue. Frozen abraded skin tissue was homog-
enized in sample buffer provided in the MPO Assay Kit (Cytostore, Calgary,
Canada). The MPO activity in tissue lysates was measured by the enzymatic
degradation of H2O2 to an oxygen radical that was then converted to a colored
compound upon binding to a hydrogen-donating chromagen supplied in the kit.
The presence of MPO was measured colorimetrically over time using a KC4
3.03 spectrophotometer (Bio-Tek Instruments, Winooski, VT).
Cytokine bead array analysis.
Two weeks following skin abrasion, ODCER transgenic and normal littermate
mice were killed and both abraded skin and distant non-abraded skin excised,
immediately frozen in liquid nitrogen, ground to a fine powder and then ho-
mogenized in phosphate-buffered saline with protease inhibitors and dithio-
threitol. The debris was cleared by centrifugation and the supernatants were
analyzed using Cytometric Bead Array reagents (BD Biosciences, San Jose,
CA) for tumor necrosis factor (TNF)-a, granulocyte-macrophage colony stim-
ulating factor, interleukin (IL)-10, IL-2, interferon-c, monocyte chemotactic
protein-1 (MCP-1), IL-6, IL-1 and keratinocyte-derived chemoattractant (KC/
CXCL1) using a BD FACSCanto II cytometer with FACSDiva software (BD
Biosciences) as per the manufacturer’s protocol.
Results
Wounding induces a prolonged hyperplastic response and tumors in
ODC transgenic mouse skin
To study the effect of elevated polyamine biosynthesis on wound healing
in skin, we used a motorized felt wheel to abrade the skin of K6/ODC
transgenic mice and their normal littermates. Abrasion removes only
the epidermal layer which is subsequently regenerated from remaining
follicular stem cells in the underlying dermis with a dramatic epidermal
hyperplastic response which peaks at 5–7 days following abrasion
(Figure 1A) (15, 24). Similar to wild-type mice (15, 25), regenerative
epidermal hyperplasia peaked at 5 days following abrasion in K6/ODC
transgenic skin. However, the degree of epidermal hyperplasia was
dramatically accentuated in K6/ODC transgenic skin and was charac-
terized by increased proliferation of the epithelial cells lining the follic-
ular cysts in the dermis (Figure 1B and E). These follicular cysts develop
in the dermal layer of non-wounded K6/ODC transgenic mice due to
degeneration of the hair follicles at 2 weeks of age resulting from
constitutively high levels of ODC activity (9, 23). We have previously
reported that epithelial cells lining these dermal cysts express increased
ODC protein and are proliferating at a higher rate compared with inter-
follicular, quiescent epidermis (26). Although epidermal hyperplasia
was dramatically increased in K6/ODC transgenic skin 5 days following
abrasion, the epidermal proliferation index, as determined by BrdU in-
corporation, was increased to a similar extent in both abraded K6/ODC
transgenic and normal littermate skin (Figure 1D–F). The exaggerated
epidermal hyperplasia in K6/ODC transgenic skin at 5 days following
abrasion was accompanied by a visible increased vascularization of the
underlying dermis (Figure 1G). The increased epidermal hyperplastic
response was prevented in K6/ODC transgenic mice by the administra-
tion of a specific inhibitor of ODC activity, 1% DFMO in their drinking
water (Figure 1C). DFMO treatment significantly attenuated the early
increase in the proliferation index and reduced the degree of epidermal
hyperplasia in not only K6/ODC transgenic but also normal littermate
mice at 5 days after abrasion (Figure 1F and data not shown).
By 3 weeks following abrasion, individual well-differentiated pap-
illomatous growths developed in all K6/ODC transgenic mice, al-
though epidermal hyperplasia was no longer observed in abraded
normal littermate skin (Figure 1H–J). These papillomas were numer-
ous, appeared in only previously abraded K6/ODC transgenic and
never normal littermate skin and appeared to develop from the cells
lining the follicular cysts that had developed in K6/ODC dermis. By 5
weeks following abrasion, the majority of wound-induced tumors had
regressed in size but small tumor-like growths were still observed at
10 weeks following abrasion (Figure 1H–J).
Use of [3H]thymidine autoradiography has been used to show that the
transit time (amount of time for a keratinocyte in the basal layer of the
epidermis to reach the topmost layer of the epidermis) is dramatically
reduced to 24 h at 3 days following abrasion (24). Since the transit time
is the lowest at 3 days past abrasion, we looked at the distance traveled
over a 9 h time period by labeled basal epidermal cells when pulsed with
[3H]thymidine at 3 days past abrasion. Labeled nuclei were detected in
higher layers of the hyperplastic, newly regenerated epidermis of abraded
K6/ODC transgenic skin (Figure 2D–F) compared with that in abraded
normal littermate skin (Figure 2A–C), suggesting that epidermal cells in
abraded K6/ODC transgenic skin have a shorter transit time at 3 days
following abrasion compared with that in abraded normal littermate skin.
Since K6/ODC transgenic mice develop morphologically abnormal
skin with alopecia and dermal cysts resulting from degenerating hair
follicles, abrasion studies were also performed using inducible ODCER
transgenic mice in which the skin retains its normal morphology with no
hair loss (11). ODC activity was induced de novo in the suprabasal
epidermis of ODCER transgenic skin with 1 week of topical application
of 4OHT prior to abrasion. With elevated ODC activity directed to the
suprabasal epidermis in ODCER transgenic skin, we have shown that the
proliferative index is increased to 7.5% in quiescent, non-wounded
ODCER skin with BrdU-labeled nuclei detected in the basal epidermal
layer and with no resulting hyperplasia (11). Abrasion increased the
proliferative index in ODCER transgenic skin (22.3% BrdU-labeled
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epidermal cells) to the same extent as that in abraded normal littermates
(22.5%) at 7 days following abrasion, but with no difference in the degree
of epidermal hyperplasia as was seen in abraded K6/ODC transgenic skin
(data not shown). At 14 days after abrasion, epidermal hyperplasia and
the epidermal proliferative index (4.6%) was greatly reduced or absent in
normal littermates, whereas 4OHT-treated ODCER mice maintained
a significantly elevated epidermal proliferative index (20.3%) and a pro-
gressive epidermal hyperplasia with papillomatous growths at the wound
site (Figure 3B). As with K6/ODC transgenic mice, the regenerative
hyperplastic wound response following abrasion persisted in ODCER
transgenic skin with increased numbers of basal and suprabasal BrdU-
labeled nuclei and tumor-like growths at 8 weeks past abrasion unlike
that seen in abraded normal littermate skin where epidermal hyperplasia
was no longer observed and scarce BrdU-labeled nuclei were confined to
the basal cells of the epidermis (Figure 3D).
Sustained activation of stromal cells following abrasion in ODCER
transgenic skin
Underlying stromal cells are activated in response to angiogenic factors
and cytokines released by activated keratinocytes in a hyperproliferative
epidermis in wound healing (27). Fibroblasts play important roles in
wound healing, including deposition of ECM as well as synthesis of
ECM-degrading proteases, regulation of inflammation and facilitation
of wound contraction. Dermal tenascin-C expression has been shown
to be strongly induced in dermal tissue adjacent to hyperproliferative
epidermis during wound healing (28) and has been implicated in angio-
genesis (29) and in modulating cell adhesion and cell motility (30).
Along with the exaggerated epidermal hyperplasia at 2 weeks following
abrasion, ODCER mice demonstrated sustained and increased dermal
expression of alpha-smooth muscle actin and tenascin-C, both markers of
activated stromal cells (Figure 3E–H). In addition to indicating the pres-
ence of activated fibroblasts, alpha-smooth muscle actin-positive peri-
cytes also stained many of the dermal blood vessels showing the
increased vascularization of the abraded ODCER skin compared with
that in normal littermate skin 2 weeks after abrasion (Figure 3F). In
marked contrast, 4OHT-treated normal littermates demonstrated minimal
epidermal hyperplasia and no reactive stromal cells by 14 days following
abrasion (Figure 3E and G).
Metabolic activation in abraded ODCER transgenic skin
In an attempt to identify biological processes that are enriched in
ODC transgene-specific differentially expressed genes following
Fig. 1. Wounding induces an exaggerated epidermal hyperplastic response and benign tumor formation in K6/ODC transgenic mouse skin. Normal littermates (A, D
and H) and K6/ODC transgenic mice (B, C, E, F and I) were abraded at 7 weeks of age. (C and F) Some K6/ODC transgenic mice were given 1% DFMO in their
drinking water for 3 days before abrasion and until killed. All mice were injected intraperitoneally with BrdU (100 lg/g body wt) 2 h before killing. (A–C) Hematoxylin-
and eosin-stained skin sections of abraded skin 5 days post abrasion with a dashed line over the abraded sites. (D and E) Skin sections were stained for cells that
incorporated BrdU by immunohistochemical staining and counterstained with hematoxylin. (F) BrdU-positive cells/1000 cells in the basal layer were counted in three to
five sections for each treatment group. The percentage of BrdU-positive cells expressed as the mean ± SEM. An asterisk denotes significant differences compared with
non-treated mice with P-values 0.05. (G) Abraded skin was excised from K6/ODC transgenic mice and their normal littermates 5 days post abrasion, and the dermal
side of the skin photographed. (H) At 5 weeks following abrasion, multiple benign tumors remained in the K6/ODC transgenic skin, whereas no tumors developed in the
fully resolved wound site in the normal littermates. (I and J) Hematoxylin- and eosin-stained sections of wound-induced tumors in K6/ODC transgenic mice at 5 weeks
following abrasion at (I) low magnification and (J) higher magnification. Arrows point to the follicular cysts that form in the dermis of K6/ODC transgenic skin. Note that
the tumors grow from the cells that line the follicular cysts. Scale bars: (A and C) 150 lm; (B) 250 lm; (D and E) 50 lm; (I) 250 lm and (J) 50 lm.
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wounding, microarray analyses of RNA isolated from the abraded
skin of K6/ODC transgenic mice and their normal littermates at 3
and 5 days following abrasion was performed. Biological processes
enriched in genes that were increased in K6/ODC transgenic skin at 3
and 5 days post abrasion compared with the response in normal lit-
termate skin included protein synthesis, vascularization and some
metabolism genes (Supplementary data and Figure S1 are available
at Carcinogenesis Online).
We used immunohistochemical analyses to look for activation of
proteins associated with protein translation in hyperplastic ODCER
epidermis at 14 days following abrasion. Activation of Akt signaling
has been shown to mediate cell proliferation and the initiation of
protein synthesis via phosphorylation and activation of mammalian
target of rapamycin (mTOR) and its downstream target S6 ribosomal
protein (S6rp) (31). Phosphorylation of S6rp correlates with increased
translation, particularly of messenger RNAs (5# terminal oligopyri-
midine tract) encoding for proteins involved in cell cycle progression
and the translational machinery. Previously we reported that increased
ODC expression in primary keratinocytes led to up-regulation of Akt/
mTOR signaling (32). Phosphorylated Akt was detected in suprabasal
epidermal cells of abraded ODCER skin, whereas no evidence of
activated Akt was detected in normal littermate skin at 14 days fol-
lowing abrasion (Figure 4). Similar to increased expression of phos-
phorylated Akt, phosphorylated S6rp was differentially increased in
Fig. 3. Chronic progressive epidermal hyperplasia and stromal cell activation in abraded ODCER transgenic skin. Normal littermates (A, C, E and G) and
ODCER transgenic mice (B, D, F and H) were topically treated with 4OHT for 1 week before abrasion until killed 14 days (A, B, E–H) or 8 weeks (C and D) after
abrasion. All mice were injected intraperitoneally with BrdU (100 lg/g body wt) 2 h before killing. (A and B) Skin sections from mice abraded 14 days previously
were stained with hematoxylin and eosin. (C and D) Skin sections from mice abraded 8 weeks previously were stained for proliferating cells that incorporated
BrdU by immunohistochemical staining. (E–H) Skin sections from mice abraded 14 days previously were immunohistochemically stained for (E and F) alpha-
smooth muscle actin or (G and H) tenascin-C protein and counterstained with hematoxylin. Arrows point to blood vessels. Scale bars: (A–F) 150 lm.
Fig. 2. Reduced epidermal transit time in K6/ODC transgenic skin following abrasion. Three days following abrasion, normal littermates (A–C) and K6/ODC
transgenic mice (D–F) were injected intraperitoneally with 30 lCi [3H]thymidine and killed 9 h later. (B and E) Higher magnification views of boxed regions in A
and D and (C and F) higher magnification views of boxed regions in B and F show silver grain deposits over proliferating cells that have incorporated
[3H]thymidine (arrows pointing at representative labeled cells). A white line marks the top epidermal layer reached by labeled cells. Scale bars: (A and D) 300 lm;
(B and E) 40 lm and (C and F) 10 lm.
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ODCER transgenic epidermis but not in normal littermate skin at 14
days following abrasion (Figure 4).
Specific to polyamine metabolism, the synthesis of the mature form
of eIF5A requires incorporation of hypusine, which is derived from the
polyamine spermidine (33, 34). Unlike that seen in normal littermate
abraded skin, levels of hypusine-containing eIF5A were elevated in the
suprabasal epidermis of ODCER transgenic skin at 14 days following
abrasion (Figure 4). The catabolic enzyme spermine oxidase was ele-
vated in abraded ODCER transgenic skin as well (Figure 4). Although
DFMO treatment prevented the epidermal hyperplastic response and
expression of these translation-associated proteins in ODCER trans-
genic skin at 2 weeks following abrasion (Figure 4), treatment with
the mTOR inhibitor, rapamycin, did not reverse the exaggerated epider-
mal hyperplasia in abraded ODCER transgenic skin (data not shown).
Wound-induced tumor formation in ODC transgenic mouse skin
dependent on recruitment of inflammatory cells
Activated keratinocytes play an important role as modulators of the
immune response following tissue injury via the secretion of cytokines
such as IL-1 and chemokines such as MCP-1 (35, 36). We assayed
abraded ODCER transgenic and normal skin for protein levels of cyto-
kines including TNF-a, granulocyte-macrophage colony stimulating
factor, IL-10, IL-2, interferon-c, MCP-1, IL-6, IL-1 and KC at a time
of early (3 days post abrasion) and late (14 days post abrasion) wound
healing. TNF-a, MCP-1, IL-6, IL-1 and KC were all elevated at early
stages of wound healing (data not shown) with no significant differ-
ences between ODC transgenic and normal littermate wound levels. By
14 days following abrasion, only MCP-1 protein levels remained sig-
nificantly elevated and only in abraded ODCER skin compared with
abraded normal littermate skin or non-abraded skin (Figure 5A). Protein
levels of TNF-a, IL-6, IL-1 and KC were no longer detected by 14 days
after abrasion in either ODCER transgenic mice or normal littermates.
The elevated levels of MCP-1 at 14 days following abrasion in ODCER
abraded skin was associated with a persistent infiltration of inflamma-
tory cells including macrophages, neutrophils and mast cells as detected
by immunohistochemical staining and increased MPO activity in
ODCER abraded skin even at 8 weeks following abrasion (Figure 5B
and D; (Supplementary data and Figure S2 are available at Carcino-
genesis Online). In contrast, inflammatory cell infiltrates were consid-
erably decreased in normal littermate skin by 14 days after wounding
(Figure 5C).
To investigate whether inflammation contributed to the wound-
induced papillomatous growth in ODCER transgenic mice following
abrasion, we treated mice following abrasion with dexamethasone,
a glucocorticoid anti-inflammatory drug. As expected, dexamethasone
treatment greatly diminished infiltrating macrophages and MCP-1
cytokine levels in abraded ODCER skin (Figure 5A and E). The pro-
liferation rate in dexamethasone-treated ODCER transgenic mice
(13.56%), as determined by the numerous BrdU-labeled basal epidermal
cells, was not significantly different from that seen in non-treated
ODCER transgenic mice (20.3%), both of which remained significantly
elevated compared with that in normal littermate mice (4.6%) at 14 days
past abrasion (Figure 5F–H). However, the exaggerated epidermal hy-
perplasia was greatly reduced and no tumor-like growths developed in
any dexamethasone-treated ODCER transgenic mice (Figure 5E and H).
To further look at the effect of elevated epidermal polyamine levels
on recruitment of inflammatory cells, ODCER transgenic mice were
administered DFMO to inhibit ODC activity during wound healing.
Not only did DFMO treatment completely prevent the exaggerated,
prolonged epidermal hyperplasia in ODCER abraded skin, but it also
significantly decreased MPO activity in both ODCER transgenic and
normal littermate skin at 14 days following abrasion (Figure 5B). In-
terestingly, whereas DFMO treatment administered throughout wound
healing normalized the wound response in ODCER transgenic mice
(Figure 6A), DFMO treatment initiated at 4 days post wounding did
not normalize the wound healing response in ODCER transgenic mice
(Figure 6). Since the early inflammatory stage of wound healing is
characterized by infiltration of the wound site with neutrophils, we
looked at the effect of DFMO treatment on neutrophil infiltration at 3
days following abrasion. As expected, immunohistochemical staining
revealed large infiltrates of neutrophils in both transgenic and normal
littermate skin at 3 days following wounding. However, the 3 days
neutrophil infiltration was greatly diminished in both transgenic and
normal littermate mice treated with DFMO (Figure 6). These data in-
dicate that inflammation contributes to the wound-initiated tumor for-
mation that is dependent on elevated epidermal polyamine biosynthesis.
Discussion
Normal wound healing is characterized by an initial inflammatory
response followed by reformation of the epithelial barrier and ECM
deposition. Ideally, inflammation quickly resolves and tissue repair
occurs in a regulated fashion. In contrast, we have found that wound
Fig. 4. Metabolic activation in abraded ODCER transgenic skin. ODCER transgenic mice and their normal littermates were topically treated with 4OHT for 1
week before abrasion and 2 weeks after abrasion. Some mice were given 1% DFMO in their drinking water beginning 3 days before abrasion and until killed 14
days later. All mice were killed 14 days after abrasion, and skin sections were immunohistochemically stained for phosphorylated Akt, phosphorylated S6rp,
hypusine-containing eIF5A and spermine oxidase protein and counterstained with hematoxylin. Scale bars for all panels: 150 lm.
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repair in skin with elevated epidermal polyamine biosynthesis exhibits
exaggerated epidermal hyperproliferation and persistent inflammation
leading to the development of benign tumors. This wound-induced
tumor formation was not observed in normal littermate mice and was
dependent on ODC activity and polyamine biosynthesis since DFMO
treatment normalizes the wound response and prevents tumor formation
in transgenic mice. Remarkably, tumors developed in these animals in
the absence of chemical carcinogens or the initiation of genetic lesions
but were dependent on inflammatory cell recruitment resulting from the
wounding and the elevated epidermal ODC activity.
Previously, we reported that elevated epidermal ODC activity in
both K6/ODC and ODCER transgenic skin increases the proliferation
index in the basal layer of non-wounded epidermis but does not stim-
ulate inflammation nor result in epidermal hyperplasia or tumor for-
mation (11). Here, we show that wounding induces exaggerated
epidermal hyperplasia and tumor growth in both K6/ODC and
ODCER transgenic mice. Re-epithelialization following wounding
involves recruitment of stem cells from the bulge area of the remain-
ing hair follicles (37). Because ODC expression was targeted to the
epidermal compartment, we chose to abrade ODC transgenic mouse
skin which only removes the epidermal layer. Abrasion precipitates
a robust predictable epidermal hyperplastic response with relative
absence of granulation tissue. In contrast, full thickness wounds result
in both epidermal hyperplasia and extensive proliferation of the un-
derlying connective tissue. Abrasion triggered a prolonged epidermal
hyperplastic response in both K6/ODC and ODCER transgenic mice.
Unlike the early hyperproliferative overshoot in K6/ODC abraded
skin which was marked by hyperplasia of cells lining follicular-
derived cysts in the dermis, the early wound healing response in in-
ducible ODCER skin was similar to that in normal littermate skin at 7
days following abrasion. The proliferation rate in newly regenerated
epidermis was similarly elevated in K6/ODC, ODCER and normal
mice at 1 week following abrasion. However, papillomatous growths
and increasing epidermal hyperplasia developed in both K6/ODC and
ODCER transgenic skin by 14–21 days following abrasion when both
the epidermal proliferation index and hyperplasia had significantly
regressed in normal littermate skin. The epidermal proliferation rate
remained significantly elevated in both K6/ODC and ODCER
Fig. 5. Persistent inflammatory cell infiltrates in ODCER transgenic skin following wounding. ODCER transgenic mice and normal littermate mice were killed
14 days following abrasion. Some mice were subcutaneously injected with dexamethasone (100 lg in 100 ll phosphate-buffered saline) near the wound site every
day starting the day after abrasion. Another group of mice was given 1% DFMO in their drinking water beginning 3 days before abrasion and until killed 14 days
after abrasion. The abraded skin was assayed for (A) MCP-1 cytokine levels by flow cytometry using Cytokine beads and (B) for MPO activity as an indicator of
neutrophil infiltrates. Values for MCP-1 protein levels and MPO activity are given as the mean ± SEM with an asterisk marking significant differences between
groups with P-values 0.05. (C–E) Skin sections from normal littermate mice (C), ODCER transgenic mice (D) and dexamethasone-treated ODCER transgenic
mice (E) at 14 days following abrasion were stained for macrophage infiltrates by immunohistochemical staining for F4/80 positive macrophages. (F–H) Skin
sections from normal littermate mice (F), ODCER transgenic mice (G) and dexamethasone-treated ODCER transgenic mice (H) at 14 days following abrasion
were stained for cells that incorporated BrdU by immunohistochemical staining. Scale bars: (C–H) 100 lm.
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transgenic skin at 14 days following abrasion compared with that
in normal littermates. Since the wound-induced tumor growth in
K6/ODC and ODCER transgenic mice slowly regressed, the majority
of wound-induced tumors in transgenic mice were most probably low
risk, terminally benign papillomas (38). Additional studies are needed
to determine whether a small subgroup of these tumors can progress to
a malignant phenotype.
Consistent with the exaggerated epidermal hyperplasia in abraded
transgenic skin, Akt and mTOR signaling remains activated in
ODCER and K6/ODC transgenic mice compared with that in normal
littermates. In addition, polyamines are known to bind to RNA (39)
and modulate both translation initiation (40, 41) and elongation (42).
Specifically spermidine is required for the formation of hypusine
which is incorporated in the posttranslational modification and
activation of the translational elongation factor, eIF5A (33, 34).
Up-regulation of these polyamine-modulated effectors of protein syn-
thesis most probably plays an important role in sustaining the high
proliferation rate and epidermal hyperplasia in wounded ODC trans-
genic skin. Because treatment with rapamycin did not reverse the
exaggerated epidermal hyperplasia in abraded ODCER transgenic skin,
it is probably that polyamine-stimulation of protein synthesis via acti-
vation of mTor signaling is not sufficient to sustain epidermal hyper-
plasia and wound-induced tumors in ODC transgenic skin. However,
treatment with an anti-inflammatory agent dramatically reduced the
epidermal hyperplasia in wounded ODCER skin without significantly
reducing the high proliferation rate in the basal epidermal layer. Fur-
thermore, inhibition of ODC activity with DFMO only normalized the
wound healing response when given from the time of abrasion but not
when initiated a few days after abrasion. DFMO suppressed not only the
epidermal proliferation rate but also the early infiltration of neutrophils
in newly abraded skin. Thus, although elevated polyamine levels stim-
ulate epidermal proliferation both in non-wounded (11) and wounded
skin, recruitment of inflammatory cells is necessary to sustain epidermal
hyperplasia and wound-induced tumors.
The persistent infiltration of inflammatory cells in abraded ODC trans-
genic skin is also accompanied with a significant increase in wound
MCP-1 production. MCP-1 levels strongly influence the infiltration of
macrophages into wounds as demonstrated by the strong influx of macro-
phages following topical application of recombinant MCP-1 to wounds
(43). Interestingly, mice that are deficient in MCP-1 exhibit defective
wound repair but with no change in the number of wound macrophages,
implicating a role for MCP-1 in macrophage activation and in promoting
epithelial and vascular growth (44). It is possible that elevated levels of
MCP-1 alters the effector state of macrophages and other inflammatory
cells, thus contributing to the dramatic hyperplastic wound response and
wound-induced tumor formation. For instance, macrophage polarization
from an M1 proinflammatory phenotype to an M2 pro-growth phenotype
(45) may be induced in a microenvironment with elevated epidermal
levels of polyamines. Besides the beneficial role of inflammatory cells
in killing invading bacteria in the wound bed, a persistant inflammatory
microenvironment found in a chronic wound can also be a risk factor for
malignant transformation (36, 46). Our data suggest that elevated poly-
amine biosynthesis contributes to ‘a wound that never heals’ phenotype
that Dvorak (16) has likened to a tumor.
Chronic wounds are characterized by a persistent inflammatory re-
sponse at the wound site, accompanied by unbalanced proteolytic ac-
tivity and a highly pro-oxidant microenvironment (36). Infiltrating
leukocytes, including neutrophils and macrophages, are a rich source
of various reactive oxygen species that are released into the wound. In
addition, the polyamine catabolic enzyme spermine oxidase, that gen-
erates both reactive oxygen species and cytotoxic aldehydes, is induced
in ODC overexpressing keratinocytes (47). Since we found that the
polyamine catabolic enzyme spermine oxidase is upregulated in the
hyperplastic epidermis of abraded ODCER transgenic mice, it is possi-
ble that increased polyamine metabolism may contribute to the gener-
ation of a more pro-oxidant wound environment and the resulting
prolonged hyperplasia and tumor growth in wounded ODCER mice.
However, we have found that treatment with neither the reactive oxygen
species scavenger, N-acetyl cysteine (48) nor with MDL-72527, an in-
hibitor of spermine oxidase activity (49, 50), prevented the wound-
induced tumor formation in ODCER transgenic mice (data not shown).
Our data suggest that increased epidermal polyamine biosynthesis ex-
acerbates the wound healing process via multiple mechanisms that stim-
ulate both epithelial proliferation and recruitment of inflammatory cells.
This study shows that wounding cooperates with increased epider-
mal ODC activity in non-dividing suprabasal epidermal cells to initi-
ate tumor formation. Arwert et al. (51) also recently reported benign
skin tumor growth following wounding in transgenic mice in which
expression of activated mitogen-activated protein kinase kinase 1 is
directed to suprabasal, non-dividing epidermal cells. The wound-
initiated tumor formation in their transgenic mouse model was de-
pendent on inflammatory cells including cd T cells and macrophages
(51). A similar wound healing phenotype is found in ODCER trans-
genic skin which is characterized by epidermal hyperproliferation
with prolonged activation of translation-associated proteins, a pro-
longed infiltration of inflammatory cells, activation of fibroblasts
and increased vascularization, all of which provide a growth factor
and cytokine-enriched stroma that can both support and promote
Fig. 6. DFMO prevents wound-induced hyperproliferative response and tumor growth in ODC transgenic mice only if given before wounding. Normal littermates
(A) and ODCER transgenic mice (B–D) were topically treated with 4OHT for 1 week before abrasion at 7 weeks of age. (A–D) ODCER transgenic mice and their
normal littermates were killed 14 days after abrasion, and skin sections were stained with hematoxylin and eosin. (C) ODCER transgenic mice were administered
1% DFMO in their drinking water for 3 days before abrasion and until killed at 14 days after wounding. (D) ODCER transgenic mice were administered 1%
DFMO in their drinking water at 4 days following abrasion and until killed at 14 days after wounding. (E–H) Normal littermates (E and G) and ODC transgenic
mice (F and H) were killed 3 days after abrasion, and skin sections immunohistochemically stained for neutrophils. (G and H) Mice were administered 1% DFMO
in their drinking water for 3 days before abrasion and until killed at 3 days after wounding. e, eschar formed at the site of abrasion; scale bars: (A–H) 150 lm.
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tumorigenesis. We propose that the ODCER transgenic mouse model
of wound healing provides a novel animal model to study the role of
chronic inflammation in malignant transformation. In addition to
stimulating proliferation of newly regenerated epidermal cells, this
study highlights the far-reaching epigenetic effects that elevated epi-
dermal polyamines impose on the dermal microenvironment to acti-
vate underlying stromal cells, enhance recruitment of inflammatory
cells and skew a normal wound healing response into pathology in-
volving tumor growth. Because these activating, modulatory effects of
polyamines act as an accelerating switch in tissue remodeling events
such as wound healing, inhibition of polyamine metabolic pathways is
an important consideration in designing not only chemopreventive
therapy but also adjunct chemotherapy in the treatment of skin cancer.
Supplementary material
Supplementary data and Figures S1 and S2 can be found at http://
carcin.oxfordjournals.org/
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